Andrea Giuffrida - Publications

University of Texas Health Science Center, San Antonio, TX, United States 
Cannabinoids, Neuroscience, Pharmacology

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Seillier A, Giuffrida A. Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26706691 DOI: 10.1016/j.euroneuro.2015.12.009  1
2015 Aguilar DD, Giuffrida A, Lodge DJ. THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia. Journal of Psychopharmacology (Oxford, England). PMID 26510449 DOI: 10.1177/0269881115612239  1
2015 Perez SM, Aguilar DD, Neary JL, Carless MA, Giuffrida A, Lodge DJ. Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26068729 DOI: 10.1038/npp.2015.169  1
2015 Bilbao A, Serrano A, Cippitelli A, Pavón FJ, Giuffrida A, Suárez J, García-Marchena N, Baixeras E, Gómez de Heras R, Orio L, Alén F, Ciccocioppo R, Cravatt BF, Parsons LH, Piomelli D, et al. Role of the satiety factor oleoylethanolamide in alcoholism. Addiction Biology. PMID 26037332 DOI: 10.1111/adb.12276  1
2015 Hruba L, Seillier A, Zaki A, Cravatt BF, Lichtman AH, Giuffrida A, McMahon LR. Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice. The Journal of Pharmacology and Experimental Therapeutics. 353: 261-8. PMID 25711338 DOI: 10.1124/jpet.115.222836  1
2015 Martinez AA, Morgese MG, Pisanu A, Macheda T, Paquette MA, Seillier A, Cassano T, Carta AR, Giuffrida A. Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats. Neurobiology of Disease. 74: 295-304. PMID 25486547 DOI: 10.1016/j.nbd.2014.11.024  1
2015 Sánchez López AJ, Román-Vega L, Ramil Tojeiro E, Giuffrida A, García-Merino A. Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients. Clinical and Experimental Immunology. 179: 119-27. PMID 25169051 DOI: 10.1111/cei.12443  1
2014 Seillier A, Dominguez Aguilar D, Giuffrida A. The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184. Pharmacology, Biochemistry, and Behavior. 124: 153-9. PMID 24911644 DOI: 10.1016/j.pbb.2014.05.022  1
2014 Deutch AY, Giuffrida A, Roberts JL. Nonclassic Signaling in the Brain From Molecules to Networks: An Introduction to Cellular and Molecular Neuroscience: Third Edition. 239-255. DOI: 10.1016/B978-0-12-397179-1.00008-7  1
2014 Giuffrida A, Martinez A. Cannabinoids and levodopa-induced dyskinesia Levodopa-Induced Dyskinesia in Parkinson's Disease. 245-264. DOI: 10.1007/978-1-4471-6503-3_14  1
2013 Seillier A, Martinez AA, Giuffrida A. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1816-24. PMID 23563893 DOI: 10.1038/npp.2013.81  1
2013 Raichlen DA, Foster AD, Seillier A, Giuffrida A, Gerdeman GL. Exercise-induced endocannabinoid signaling is modulated by intensity. European Journal of Applied Physiology. 113: 869-75. PMID 22990628 DOI: 10.1007/s00421-012-2495-5  1
2013 Matricon J, Giuffrida A. Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders. 73-101. DOI: 10.1007/978-1-4614-7940-6_5  1
2012 Carta AR, Giuffrida A, Fisone G. Dyskinesia in Parkinson's disease therapy. Parkinson's Disease. 2012: 639080. PMID 23304638 DOI: 10.1155/2012/639080  1
2012 Denora N, Cassano T, Laquintana V, Lopalco A, Trapani A, Cimmino CS, Laconca L, Giuffrida A, Trapani G. Novel codrugs with GABAergic activity for dopamine delivery in the brain. International Journal of Pharmaceutics. 437: 221-31. PMID 22940209 DOI: 10.1016/j.ijpharm.2012.08.023  1
2012 Paquette MA, Martinez AA, Macheda T, Meshul CK, Johnson SW, Berger SP, Giuffrida A. Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptors. The European Journal of Neuroscience. 36: 3224-34. PMID 22861201 DOI: 10.1111/j.1460-9568.2012.08243.x  1
2012 Gould GG, Seillier A, Weiss G, Giuffrida A, Burke TF, Hensler JG, Rock C, Tristan A, McMahon LR, Salazar A, O'Connor JC, Satsangi N, Satsangi RK, Gu TT, Treat K, et al. Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 38: 260-9. PMID 22542870 DOI: 10.1016/j.pnpbp.2012.04.011  1
2012 Giuffrida A, Seillier A. New insights on endocannabinoid transmission in psychomotor disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 38: 51-8. PMID 22521335 DOI: 10.1016/j.pnpbp.2012.04.002  1
2012 Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'. The Journal of Experimental Biology. 215: 1331-6. PMID 22442371 DOI: 10.1242/jeb.063677  1
2012 Martinez A, Macheda T, Morgese MG, Trabace L, Giuffrida A. The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. Neuroscience Research. 72: 236-42. PMID 22192465 DOI: 10.1016/j.neures.2011.12.006  1
2011 Cunningham RL, Macheda T, Watts LT, Poteet E, Singh M, Roberts JL, Giuffrida A. Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion. Hormones and Behavior. 60: 617-24. PMID 21907204 DOI: 10.1016/j.yhbeh.2011.08.012  1
2011 Seillier A, Giuffrida A. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats. Pharmacology, Biochemistry, and Behavior. 98: 583-6. PMID 21421000 DOI: 10.1016/j.pbb.2011.03.010  1
2010 Solbrig MV, Fan Y, Hermanowicz N, Morgese MG, Giuffrida A. A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats. Experimental Neurology. 226: 231-41. PMID 20832403 DOI: 10.1016/j.expneurol.2010.09.003  1
2010 Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 373-86. PMID 19607756 DOI: 10.1017/S146114570999023X  1
2010 Giuffrida A, McMahon LR. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability. Prostaglandins & Other Lipid Mediators. 91: 90-103. PMID 19523530 DOI: 10.1016/j.prostaglandins.2009.05.004  1
2009 Cunningham RL, Giuffrida A, Roberts JL. Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta. Endocrinology. 150: 5539-48. PMID 19837873 DOI: 10.1210/en.2009-0640  1
2009 Seillier A, Giuffrida A. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801. Behavioural Brain Research. 204: 410-5. PMID 19716985 DOI: 10.1016/j.bbr.2009.02.007  1
2009 Fride E, Gobshtis N, Dahan H, Weller A, Giuffrida A, Ben-Shabat S. The endocannabinoid system during development: emphasis on perinatal events and delayed effects. Vitamins and Hormones. 81: 139-58. PMID 19647111 DOI: 10.1016/S0083-6729(09)81006-6  1
2009 Price DA, Martinez AA, Seillier A, Koek W, Acosta Y, Fernandez E, Strong R, Lutz B, Marsicano G, Roberts JL, Giuffrida A. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. The European Journal of Neuroscience. 29: 2177-86. PMID 19490092 DOI: 10.1111/j.1460-9568.2009.06764.x  1
2009 Koethe D, Giuffrida A, Schreiber D, Hellmich M, Schultze-Lutter F, Ruhrmann S, Klosterkötter J, Piomelli D, Leweke FM. Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 194: 371-2. PMID 19336792 DOI: 10.1192/bjp.bp.108.053843  1
2009 Koethe D, Schreiber D, Giuffrida A, Mauss C, Faulhaber J, Heydenreich B, Hellmich M, Graf R, Klosterkötter J, Piomelli D, Leweke FM. Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 301-5. PMID 19137236 DOI: 10.1007/s00702-008-0169-6  1
2009 Morgese MG, Cassano T, Gaetani S, Macheda T, Laconca L, Dipasquale P, Ferraro L, Antonelli T, Cuomo V, Giuffrida A. Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2. Neurochemistry International. 54: 56-64. PMID 19010365 DOI: 10.1016/j.neuint.2008.10.007  1
2007 Morgese MG, Cassano T, Cuomo V, Giuffrida A. Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. Experimental Neurology. 208: 110-9. PMID 17900568 DOI: 10.1016/j.expneurol.2007.07.021  1
2007 Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Kranaster L, Neatby MA, Schneider M, Gerth CW, Hellmich M, Klosterkötter J, Piomelli D. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophrenia Research. 94: 29-36. PMID 17566707 DOI: 10.1016/j.schres.2007.04.025  1
2007 Ferrer B, Bermúdez-Silva FJ, Bilbao A, Alvarez-Jaimes L, Sanchez-Vera I, Giuffrida A, Serrano A, Baixeras E, Khaturia S, Navarro M, Parsons LH, Piomelli D, Rodríguez de Fonseca F. Regulation of brain anandamide by acute administration of ethanol. The Biochemical Journal. 404: 97-104. PMID 17302558 DOI: 10.1042/BJ20061898  1
2007 Price DA, Owens WA, Gould GG, Frazer A, Roberts JL, Daws LC, Giuffrida A. CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. Journal of Neurochemistry. 101: 389-96. PMID 17250681 DOI: 10.1111/j.1471-4159.2006.04383.x  1
2007 Schreiber D, Harlfinger S, Nolden BM, Gerth CW, Jaehde U, Schömig E, Klosterkötter J, Giuffrida A, Astarita G, Piomelli D, Markus Leweke F. Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry. Analytical Biochemistry. 361: 162-8. PMID 17196922 DOI: 10.1016/j.ab.2006.11.027  1
2006 Hardison S, Weintraub ST, Giuffrida A. Quantification of endocannabinoids in rat biological samples by GC/MS: technical and theoretical considerations. Prostaglandins & Other Lipid Mediators. 81: 106-12. PMID 17085319 DOI: 10.1016/j.prostaglandins.2006.08.002  1
2005 McPartland JM, Giuffrida A, King J, Skinner E, Scotter J, Musty RE. Cannabimimetic effects of osteopathic manipulative treatment. The Journal of the American Osteopathic Association. 105: 283-91. PMID 16118355  1
2005 Solbrig MV, Adrian R, Baratta J, Piomelli D, Giuffrida A. A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. Experimental Neurology. 194: 355-62. PMID 16022863 DOI: 10.1016/j.expneurol.2005.02.017  1
2004 Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkötter J, Piomelli D. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 2108-14. PMID 15354183 DOI: 10.1038/sj.npp.1300558  1
2003 Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system. Neuroreport. 14: 2209-11. PMID 14625449 DOI: 10.1097/01.wnr.0000097048.56589.47  1
2003 Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A. Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. The European Journal of Neuroscience. 18: 1607-14. PMID 14511339 DOI: 10.1046/j.1460-9568.2003.02896.x  1
2002 Schuel H, Burkman LJ, Lippes J, Crickard K, Forester E, Piomelli D, Giuffrida A. N-Acylethanolamines in human reproductive fluids. Chemistry and Physics of Lipids. 121: 211-27. PMID 12505702 DOI: 10.1016/S0009-3084(02)00158-5  1
2002 Schuel H, Burkman LJ, Lippes J, Crickard K, Mahony MC, Giuffrida A, Picone RP, Makriyannis A. Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Molecular Reproduction and Development. 63: 376-87. PMID 12237954 DOI: 10.1002/mrd.90021  1
2002 Schäbitz WR, Giuffrida A, Berger C, Aschoff A, Schwaninger M, Schwab S, Piomelli D. Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke; a Journal of Cerebral Circulation. 33: 2112-4. PMID 12154273 DOI: 10.1161/01.STR.0000023491.63693.18  1
2001 Rodríguez de Fonseca F, Navarro M, Gómez R, Escuredo L, Nava F, Fu J, Murillo-Rodríguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D. An anorexic lipid mediator regulated by feeding. Nature. 414: 209-12. PMID 11700558 DOI: 10.1038/35102582  1
2001 Giuffrida A, Beltramo M, Piomelli D. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. The Journal of Pharmacology and Experimental Therapeutics. 298: 7-14. PMID 11408519  1
2000 Giuffrida A, Piomelli D. The endocannabinoid system: a physiological perspective on its role in psychomotor control. Chemistry and Physics of Lipids. 108: 151-8. PMID 11106788 DOI: 10.1016/S0009-3084(00)00193-6  1
2000 Calignano A, Kátona I, Désarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D. Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature. 408: 96-101. PMID 11081515 DOI: 10.1038/35040576  1
2000 Giuffrida A, Rodriguez de Fonseca F, Nava F, Loubet-Lescoulié P, Piomelli D. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. European Journal of Pharmacology. 408: 161-8. PMID 11080522 DOI: 10.1016/S0014-2999(00)00786-X  1
2000 Piomelli D, Giuffrida A, Calignano A, Rodríguez de Fonseca F. The endocannabinoid system as a target for therapeutic drugs. Trends in Pharmacological Sciences. 21: 218-24. PMID 10838609 DOI: 10.1016/S0165-6147(00)01482-6  1
2000 Giuffrida A, Rodríguez de Fonseca F, Piomelli D. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Analytical Biochemistry. 280: 87-93. PMID 10805525 DOI: 10.1006/abio.2000.4509  1
2000 Giuffrida A, Désarnaud F, Piomelli D. Endogenous cannabinoid signaling and psychomotor disorders. Prostaglandins & Other Lipid Mediators. 61: 63-70. PMID 10785542 DOI: 10.1016/S0090-6980(00)00055-1  1
2000 Beltramo M, de Fonseca FR, Navarro M, Calignano A, Gorriti MA, Grammatikopoulos G, Sadile AG, Giuffrida A, Piomelli D. Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 3401-7. PMID 10777802  1
1999 Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D. Elevated endogenous cannabinoids in schizophrenia. Neuroreport. 10: 1665-9. PMID 10501554  1
1999 Giuffrida A, Parsons LH, Kerr TM, Rodríguez de Fonseca F, Navarro M, Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nature Neuroscience. 2: 358-63. PMID 10204543 DOI: 10.1038/7268  1
1998 Piomelli D, Beltramo M, Giuffrida A, Stella N. Endogenous cannabinoid signaling. Neurobiology of Disease. 5: 462-73. PMID 9974178 DOI: 10.1006/nbdi.1998.0221  1
1998 Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 394: 277-81. PMID 9685157 DOI: 10.1038/28393  1
1998 Focarelli R, Giuffrida A, Capparelli S, Scibona M, Menchini Fabris F, Francavilla F, Francavilla S, Giovampaola CD, Rosati F. Specific localization in the equatorial region of gp20, a 20 kDa sialylglycoprotein of the capacitated human spermatozoon acquired during epididymal transit which is necessary to penetrate zona-free hamster eggs. Molecular Human Reproduction. 4: 119-25. PMID 9542968 DOI: 10.1093/molehr/4.2.119  1
1998 Giuffrida A, Piomelli D. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. Febs Letters. 422: 373-6. PMID 9498819 DOI: 10.1016/S0014-5793(98)00046-5  1
1997 Giuffrida A, Focarelli R, Lampariello R, Rosati F. Glycan chains play a role in the axonemal cytoskeleton disassembly activity of the 35 kDa glycoprotein of the spermathecal extract of Eyprepocnemis plorans (Insecta, Orthoptera) Insect Biochemistry and Molecular Biology. 27: 315-321. DOI: 10.1016/S0965-1748(97)00006-4  1
1996 Calandra C, Giuffrida A. [Psychopathological study of schizophrenia according to the pyramidal model]. Minerva Psichiatrica. 37: 1-4. PMID 8926854  1
1996 Viscuso R, Narcisi L, Sottile L, Giuffrida A. Secretory product of the lateral oviducts of Baculum thaii haus. (Phasmida: Phasmatidae) and its change during egg transit International Journal of Insect Morphology and Embryology. 25: 369-379. DOI: 10.1016/S0020-7322(96)00018-9  1
1996 Giuffrida A, Focarelli R, Lampariello R, Thole H, Rosati F. Purification and properties of a 35 kDa glycoprotein from spermathecal extract of Eyprepocnemis plorans (insecta, Orthoptera) with axonemal cytoskeleton disassembly activity Insect Biochemistry and Molecular Biology. 26: 347-354. DOI: 10.1016/0965-1748(95)00095-X  1
1995 Focarelli R, Giuffrida A, Rosati F. Changes in the sialylglycoconjugate distribution on the human sperm surface during in-vitro capacitation: partial purification of a 20 kDa sialylglycoprotein of capacitated spermatozoa. Human Reproduction (Oxford, England). 10: 2755-9. PMID 8567809 DOI: 10.1093/molehr/1.8.369  1
1991 Giuffrida A. Connecting flagellar elements in the sperm of Eyprepocnemis plorans (Charpentier) (Orthoptera : Acrididae) International Journal of Insect Morphology and Embryology. 20: 319-322. DOI: 10.1016/0020-7322(91)90020-A  1
1990 Longo G, Viscuso R, Sottile L, Giuffrida A. Lectin binding to the egg envelopes in Eyprepocnemis plorans (Charp.) (Orthoptera, Acrididae). Basic and Applied Histochemistry. 34: 127-34. PMID 2222399  1
Show low-probability matches.